172 related articles for article (PubMed ID: 14531822)
1. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
Santamaria R; Almaden Y; Felsenfeld A; Martin-Malo A; Gao P; Cantor T; Aljama P; Rodriguez M
Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
Lewin E; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
[TBL] [Abstract][Full Text] [Related]
4. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
6. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
[TBL] [Abstract][Full Text] [Related]
7. Dynamic tests of parathyroid hormone secretion using hemodialysis and calcium infusion cannot be compared.
Moysés RM; Pereira RC; Machado dos Reis L; Sabbaga E; Jorgetti V
Kidney Int; 1999 Aug; 56(2):659-65. PubMed ID: 10432406
[TBL] [Abstract][Full Text] [Related]
8. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
Felsenfeld AJ; Ross D; Rodriguez M
J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.
Ouseph R; Leiser JD; Moe SM
J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117
[TBL] [Abstract][Full Text] [Related]
10. Feline parathyroid hormone: validation of hormonal assays and dynamics of secretion.
Pineda C; Aguilera-Tejero E; Raya AI; Diez E; Rodriguez M; Lopez I
Domest Anim Endocrinol; 2012 May; 42(4):256-64. PubMed ID: 22365655
[TBL] [Abstract][Full Text] [Related]
11. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
[TBL] [Abstract][Full Text] [Related]
12. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
[TBL] [Abstract][Full Text] [Related]
13. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.
Felsenfeld AJ; Rodríguez M; Aguilera-Tejero E
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1283-305. PubMed ID: 17942777
[TBL] [Abstract][Full Text] [Related]
15. Effect of rate of calcium reduction and a hypocalcemic clamp on parathyroid hormone secretion: a study in dogs.
Estepa JC; Aguilera-Tejero E; Almaden Y; Rodriguez M; Felsenfeld AJ
Kidney Int; 1999 May; 55(5):1724-33. PubMed ID: 10231434
[TBL] [Abstract][Full Text] [Related]
16. A reduced PTH response to hypocalcemia after a short period of hypercalcemia: a study in dogs.
Sánchez J; Aguilera-Tejero E; Estepa JC; Almadén Y; Rodríguez M; Felsenfeld AJ
Kidney Int Suppl; 1996 Dec; 57():S18-22. PubMed ID: 8941917
[TBL] [Abstract][Full Text] [Related]
17. Differences in the dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism.
Felsenfeld AJ; Jara A; Pahl M; Bover J; Rodriguez M
J Am Soc Nephrol; 1995 Nov; 6(5):1371-8. PubMed ID: 8589311
[TBL] [Abstract][Full Text] [Related]
18. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.
Dunlay R; Rodriguez M; Felsenfeld AJ; Llach F
Kidney Int; 1989 Dec; 36(6):1093-8. PubMed ID: 2601258
[TBL] [Abstract][Full Text] [Related]
19. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
20. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
